ABD News, July 2010, Vol. 10, no. 7

weekly newsletter

ABD News, August 2010, Vol. 10, no. 8

weekly newsletter

ABD News, September 2010, Vol. 10, no. 9

weekly newsletter

ABD News, October 2010, Vol. 10, no. 10

weekly newsletter

ABD News, November 2010, Vol. 10, no. 11

weekly newsletter

ABD News, December 2010, Vol. 10, no. 12

weekly newsletter

ABD News, January 2011, Vol. 11, no. 1

weekly newsletter

ABD News, February 2011, Vol. 11, no. 2

weekly newsletter

ABD News, March 2011, Vol. 11, no. 3

weekly newsletter

ABD News, May 2011, Vol. 11, no. 5

weekly newsletter

ABD Promos, June 2011, Vol. 11, no. 6

weekly newsletter

Hyperferritinémie associée au syndrome métabolique: une nouvelle cible thérapeutique [Dysmetabolic hyperferritinemia: a new target for treatment?].

Dysmetabolic hyperferritinemia is currently the most frequent cause of elevated ferritin levels in the general population. Whether dysmetabolic hyperferritinemia is a cause or an effect of insulin resistance is still a matter of debate. Still, several findings have been well established: increased iron intake or elevated ferritin levels are individual risk factors for diabetes, metabolic syndrome or gestational diabetes. When in presence of dysmetabolic hyperferritinemia, a small number of randomized controlled trials have suggested that therapeutic measures aimed at reducing ferritin levels such as low red meat consumption, deferoxamin or therapeutic phlebotomies have shown a beneficial effect on glucose homeostasis, lipid profile and impaired hepatic markers observed in non-alcoholic steatohepatitis.

ABD Promos, July 2011, Vol. 11, no. 7

weekly newsletter

ABD Promos, September 2011, Vol. 11, no. 9

Monthly newsletter produced by the Iowa Department of Commerce, Division of Alcoholic Beverages.

ABD Promos, August 2011, Vol. 11, no. 8

Monthly newsletter produced by the Iowa Department of Commerce, Division of Alcoholic Beverages.